© 2019 RSM US LLP. All rights reserved.
Financial Advisory Ideas & Insights
Our latest perspectives on valuation, disputes, financial investigations and IPO readiness
most recent insights
Leveraging data analytics and monitoring when implementing and testing compliance programs can help evaluate the efficacy of your program.
Read RSM’s summary of incremental recommendations to corporate compliance programs based on DOJ’s recently issued guidance.
How can life sciences companies looking to go public position themselves for success? It’s all about setting the stage early on.
Compare your anti-money laundering program to that of your peers with RSM's best practice and benchmarking report
Access RSM's latest research on how financial institutions are responding to anti-money laundering (AML) program requirements.
Is your company ready for an IPO? Attend this webcast for accounting, tax and financial reporting perspective.
Learn how cyberthreat intelligence will provide financial institutions with a deeper understanding of potential threats.